Evidence mapPaperPMID 42401722Full record

ArticleAnnals of surgical oncology2026

Robotic Remnant Total Pancreatectomy After Robotic Pancreaticoduodenectomy (with video).

Yoshiki Fujiyama, Taiga Wakabayashi, Malek Alomari, Marco Colella, Kohei Mishima, Yusuke Nie, Kazuharu Igarashi, Shozo Mori, Takahiro Ozaki, Go Wakabayashi

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yoshiki FujiyamaCenter for Advanced Treatment of Hepatobiliary and Pancreatic Diseases, Ageo Central General Hospital, Saitama, Japan. fujiyama.yoshiki@kitasato-u.ac.jp.
Taiga WakabayashiCenter for Advanced Treatment of Hepatobiliary and Pancreatic Diseases, Ageo Central General Hospital, Saitama, Japan.
Malek AlomariCenter for Advanced Treatment of Hepatobiliary and Pancreatic Diseases, Ageo Central General Hospital, Saitama, Japan.
Marco ColellaCenter for Advanced Treatment of Hepatobiliary and Pancreatic Diseases, Ageo Central General Hospital, Saitama, Japan.
Kohei MishimaCenter for Advanced Treatment of Hepatobiliary and Pancreatic Diseases, Ageo Central General Hospital, Saitama, Japan.
Yusuke NieCenter for Advanced Treatment of Hepatobiliary and Pancreatic Diseases, Ageo Central General Hospital, Saitama, Japan.
Kazuharu IgarashiCenter for Advanced Treatment of Hepatobiliary and Pancreatic Diseases, Ageo Central General Hospital, Saitama, Japan.
Shozo MoriCenter for Advanced Treatment of Hepatobiliary and Pancreatic Diseases, Ageo Central General Hospital, Saitama, Japan.
Takahiro OzakiCenter for Advanced Treatment of Hepatobiliary and Pancreatic Diseases, Ageo Central General Hospital, Saitama, Japan.
Go WakabayashiCenter for Advanced Treatment of Hepatobiliary and Pancreatic Diseases, Ageo Central General Hospital, Saitama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe number of robotic pancreaticoduodenectomy (R-PD) and robotic distal pancreatectomy (R-DP) procedures has been increasing worldwide. However, there are no reports on clinical cases of robotic remnant total pancreatectomy (R-RTP). This report presents a standardized surgical technique for R-RTP after R-PD based on the authors' experience with three clinical cases. The procedure is presented with accompanying surgical videos, and its feasibility and potential advantages are discussed. PURPOSE: This study presents a standardized surgical technique for R-RTP following R-PD, based on our experience with three clinical cases. The procedure is presented with accompanying surgical videos, and its feasibility and potential advantages are discussed.

methodsThe standardized surgical procedure for R-RTP involves patient setting and port placement, intra-abdominal adhesiolysis, dissection of the jejunal loop, encirclement and dissection of the splenic artery and vein, dissection of the dorsal pancreatic border from the retroperitoneum, dissection of the splenocolic ligament and the gastrosplenic ligament, and specimen removal. In this study, the clinicopathologic features and short-term outcomes of the three cases were retrospectively analyzed.

resultsThe patients had a mean operative time 332 min (range, 277-425 min), an intraoperative blood loss of 168 mL (range, 50-254 mL), and a postoperative hospital stay of 13.3 days (range, 10-20 days). No postoperative complications or mortality were observed. All the patients achieved pathologic R0 resection and at this writing are alive without recurrence.

conclusionsThis study suggests that R-RTP after R-PD may be technically feasible. The minimally invasive approach, standardization of the surgical procedure, and appropriate metabolic management may contribute to favorable perioperative outcomes and postoperative recovery.

Indexed as

Minimally invasive surgeryPancreatic tumorRemnant total pancreatectomyRobotic pancreatectomyRobotic surgery

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.